PL
 |
EN
Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na https://bibliotekanauki.pl
Ograniczanie wyników
Czasopisma help
  1. 58 Bulletin of the Veterinary Institute in Puławy
  2. 25 Archivum Immunologiae et Therapiae Experimentalis
  3. 9 Lecznica Dużych Zwierząt. Ogólnopolski Kwartalnik dla Lekarzy Weterynarii
  4. 9 Polish Journal of Veterinary Sciences
  5. 8 Acta Parasitologica
Więcej...
Lata help
  1. 1 2024
  2. 2 2023
  3. 7 2022
  4. 11 2021
  5. 8 2020
Więcej...
Autorzy help
  1. 7 Borkowska-Opacka B.
  2. 6 Brydak L. B.
  3. 6 Szweda W.
  4. 6 Truszczynski M.
  5. 5 Kedrak A.
Więcej...
Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 180

Liczba wyników na stronie
first rewind previous Strona / 9 next fast forward last
Wyniki wyszukiwania
Wyszukiwano:
w słowach kluczowych:  vaccine
help Sortuj według:

help Ogranicz wyniki do:
first rewind previous Strona / 9 next fast forward last
1
Content available Use of antihistamines for COVID-19 vaccine recipients with risk of anaphylaxis
100%
Grabowski J. , Wolff M. , Pettersson S. D. , Brancewicz T. , Bidzan L.
European Journal of Translational and Clinical Medicine
|
2022
|
tom 5
|
nr 1
8-11
EN
Allergic reactions to COVID-19 vaccine ranging from mild to severe have been reported in patients with a history of anaphylaxis. Currently, no guidelines are available regarding prevention of allergic reactions in patients with high-risk of anaphylaxis who plan on receiving the SARS-CoV-2 vaccine. In this case-series study, two patients with a history of anaphylaxis had taken antihistaminic drugs prior to their BNT162b2 vaccinations and experienced no major allergic reactions afterwards. The use of antihistamines prior to COVID-19 vaccination may have affected the outcome of the two subjects with history of anaphylaxis history. However, further studies are needed to evaluate efficacy, generalizability and safety of the approach presented in this case-series.
2
Content available Serum levels of anti-corona virus specific-IgG and -IgM antibodies in COVID-19 patients at admission and at discharge
100%
Introduction. Clear understanding of duration of antibody based protective immunity following natural infection with SARSCoV-2 will give idea about the efficacy of proposed prophylactic vaccines against SARS-CoV-2, establishment of herd immunity and use of convalescent plasma. Aim. This study clarified the kinetics and magnitude of the initial antibody response against SARS-CoV-2 in a cohort of symptomatic COVID-19 patients from Ibadan, Nigeria. Material and methods. This study quantified immunoglobulin M (IgM) and G (IgG) antibodies recognizing the SARS-CoV-2 Spike (S) protein in 35 symptomatic COVID-19 patients at admission and at discharge using ELISA. Results. CovIgG was positive in none (0)% and 20% of COVID-19 patients at admission and at discharge respectively while CovIgM was positive in 54% and 69% of COVID-19 patients at admission and at discharged respectively. The level of CovIgG was significantly higher in COVID-19 patients at discharge compared with the level at admission while the level of CovIgM was insignificantly reduced in COVID-19 patients at discharge compared with the level at admission. Conclusion. The data indicates increased anti-SARS-COV-2 IgG Spike antibody in symptomatic COVID-19 at discharge, thus providing basis for antibody-based therapies to treat COVID-19 patients
European Journal of Clinical and Experimental Medicine
|
2021
|
nr 1
5-9
EN
Introduction. Clear understanding of duration of antibody based protective immunity following natural infection with SARSCoV-2 will give idea about the efficacy of proposed prophylactic vaccines against SARS-CoV-2, establishment of herd immunity and use of convalescent plasma. Aim. This study clarified the kinetics and magnitude of the initial antibody response against SARS-CoV-2 in a cohort of symptomatic COVID-19 patients from Ibadan, Nigeria. Material and methods. This study quantified immunoglobulin M (IgM) and G (IgG) antibodies recognizing the SARS-CoV-2 Spike (S) protein in 35 symptomatic COVID-19 patients at admission and at discharge using ELISA. Results. CovIgG was positive in none (0)% and 20% of COVID-19 patients at admission and at discharge respectively while CovIgM was positive in 54% and 69% of COVID-19 patients at admission and at discharged respectively. The level of CovIgG was significantly higher in COVID-19 patients at discharge compared with the level at admission while the level of CovIgM was insignificantly reduced in COVID-19 patients at discharge compared with the level at admission. Conclusion. The data indicates increased anti-SARS-COV-2 IgG Spike antibody in symptomatic COVID-19 at discharge, thus providing basis for antibody-based therapies to treat COVID-19 patients
3
Content available Practical use of gE deleted vaccine in IBR control programs: field case reports
100%
Siebert V. , Auer S. , Kreczdorn D. , Strube W. , Schmeer N.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
4
Content available Development of paediatric multivalent combined vaccines
100%
Andre F. E.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
5
Content available Assesment of inactivated split influenza vaccine in patients with glomerulonephritis
100%
Brydak L. B. , Rajkowski T. , Machala M. , Weglarska J. , Sieniawska M.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
6
Content available Concentrated and purified rabies vaccine for parenteral application in domestic animals
100%
Benisek Z. , Suliova J. , Svrcek S. , Zavadova J. , Durove A. , Ondrejka R.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
7
High-throughput sequencing in vaccine research
88%
Pasik K. , Domanska-Blicharz K.
Journal of Veterinary Research
|
2021
|
tom 65
|
nr 2
8
Content available Vaccine Discourse and Vaccine-Induced Sufferings: Discourse analysis of the promotion and hesitation of vaccination in Japan
88%
Sato A.
Language, Discourse & Society
|
2024
|
tom 12
|
nr 1 (23)
13-35
EN
The pandemic of the new coronavirus and the introduction of coronavirus vaccines prompted the production of vaccines and vaccine discourses around the world. The same situation has been observable in Japan. The purpose of this study is to discuss what I call “the social phenomenon of vaccines” in Japan. The present article will describe the characteristics of the vaccine discourse and consider the relationship between the vaccine discourse and vaccine-induced sufferings, which refer to the experience of social damages and difficulties caused by vaccines. Firstly, I will review the research method of the previous studies of vaccination. It has been shown that both pro-vaccine and anti-vaccine existed from the beginning of the history of vaccination, and in that sense, the existence of both pro-vaccine and anti-vaccine can be considered as a part of “the social phenomenon of vaccines” from the beginning. Inspired by the Strong Program, I will explain a method which would enable me to describe both pro and anti-vaccine without a priori assumptions. One such method can be found in the repertoire analysis by Gilbert and Mulkey (1984), who analyzed controversies in scientific research. Following their method, I will explore how the vaccine discourse was developed in Japan. The vaccine discourse in Japan is found in three different types of literature, which discuss vaccine promotion, vaccine harms, and vaccine safety. Secondly, I will identify three kinds of repertoires: “componentist repertoire”, “manipulationist repertoire” and “psychologism repertoire”. I will then discuss the features of “the social phenomenon of vaccines” by examining the relationship among these repertoires and how these repertoires work. Finally, I will discuss how vaccine discourse is related to the discourse of vaccine-induced sufferings. In conclusion, vaccination, by its very nature, cannot be separated from the impossibility of direct experience of vaccination. Therefore, the more vaccine develops, the more vaccine discourse flourishes.
9
Content available Hilary Koprowski - polski lekarz, wirusolog i immunolog
88%
Marcin Marczyński M. , Adrian Pękacz A.
Humanum. Międzynarodowe Studia Społeczno-Humanistyczne
|
2018
|
nr 1(28)
119-123
EN
The aim of article is representation of the silhouette professors Koprowski, his scientific achievements. Hilary Koprowski was co-founder vaccine against poliomyelitis. I described childhood and youth professors, his scientific achievements, publications and related exam by him positions. I discussed controversies about vaccine against disease Heinego-Medina. Writing about achievements mentioned awards and decorations for scientific activity. I presented autobiographical books and biographical sacred profeesor Koprowski. At the end found themselves curiosities and another information from life professor.
10
A universal flu vaccine
88%
Kesik-Brodacka M. , Plucienniczak G.
Acta Biochimica Polonica
|
2014
|
tom 61
|
nr 3
11
Influenza virus hemagglutinin as a vaccine antigen produced in bacteria
88%
Saczynska V.
Acta Biochimica Polonica
|
2014
|
tom 61
|
nr 3
12
Content available Study on immunity duration in polecats inoculated with inactivated vaccine against canine distemper
88%
Ultmelidze G. O. , Starov S. K. , Evseev A. M. , Sarbasov A. S. , Gerasimova N. I. , Gusev A. A. , Markina M. I.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
13
Content available Characterization of rinderpest virus vaccine strains by molecular biology techniques
88%
Ayanot P. K. , Kolosov S. N. , Lomakin A. I. , Starov S. K. , Drygin V. V. , Gusev A. A.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
14
Content available Bacterial ghosts as multifunctional vaccine particles
88%
Lubitz W.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
15
Content available Rabies incidence and night counting of foxes in France
88%
Aubert M. , Vuillaume P.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
16
Content available Virus vaccine against sheep pox prepared on the passaged culture of kids' gonads
88%
Diev V. I. , Sokholov L. N.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
17
Content available Development of vaccinia virus recombinants expressing various glycoproteins of varicella-zoster virus
88%
Nemeckova S. , Maresova L. , Ludvikova V. , Hainz P. , Kutinova L.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
18
Content available An attempt to evaluate the efficacy of vaccines against pasteurellosis in rabbits
88%
Borkowska-Opacka B. , Rutkowska-Jurga I. , Truszczynski M. , Kozaczynski W.
Bulletin of the Veterinary Institute in Puławy
|
1996
|
tom 40
|
nr 1
EN
The goal of the studies was to evaluate the protective value of vaccines against pasteurellosis in rabbits. The vaccines comprised antigens to serotypes 3 and 12 of Pasteurella multocida with two different adjuvants: emulsigen and aluminium hydroxide gel. The two vaccines given subcutaneusly either once or twice at a dose of 1 ml protected rabbits markedly against intranasal infection with the virulent strains of examined serotypes. A substantial efficacy of these vaccines was supported by the occurrence of specific precipitins against somatic antigens of serotypes 3 and 12 present in the sera of immunised rabbits even 5 weeks after vaccination
19
Content available New generation adjuvants for subunit vaccines and their potential use in active immunotherapy
88%
Garcon N.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
20
Content available Novel approaches for developing vaccines
88%
Babiuk L. A.
Bulletin of the Veterinary Institute in Puławy
|
1998
|
tom 42
|
nr 1
first rewind previous Strona / 9 next fast forward last
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.